What is Azuloxa used for?

Azuloxa is indicated for Gastric ulcer.

What development phase is Azuloxa in?

Azuloxa is FDA-approved (marketed).

What is the generic name of Azuloxa?

EGUALEN is the generic (nonproprietary) name of Azuloxa.

Last reviewed 2026-04-20 · How we verify

Azuloxa (EGUALEN)

FDA-approved active Small molecule Quality 13/100

EGUALEN (Azuloxa) is a marketed drug primarily indicated for the treatment of gastric ulcers, leveraging its mechanism of inhibiting stomach acid production to facilitate healing and prevention. A key strength of EGUALEN is its strong patent protection, with the key composition patent expiring in 2028, providing a significant barrier to generic competition. The primary risk for EGUALEN is the potential loss of exclusivity post-2028, which could lead to increased competition from generics.

At a glance

Generic name	EGUALEN
Modality	Small molecule
Therapeutic area	Dermatology
Phase	FDA-approved

Approved indications

Gastric ulcer

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Azuloxa CI brief — competitive landscape report
Azuloxa updates RSS · CI watch RSS